A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Enrolling by invitation · Phase 3 · NCT04880876
Conditions: Irritable Bowel Syndrome
At a glance
- Research payments reported, 2025
- $22,067
- U.S. investigators named
- 6
- Sites paid
- 7
- Planned or actual enrollment
- 124
About the trial
- Sponsor
- AbbVie
- Tested
- 25mg Eluxadoline (drug), 100mg Eluxadoline (drug)
- Dates
- Started 2021-08-13; completion 2032-12
- Results posted
- Not yet
This study will assess the long-term safety of oral Eluxadoline administered to pediatric participants with IBS-D who have completed study intervention in the Phase 2 study 3030-202-002 or the Phase 3 study 3030-303-002.
From ClinicalTrials.gov, last updated 2025-07-17. Full record, eligibility and contacts (opens in a new tab)
Industry funding
AbbVie Inc. reported $22,067 in research payments for this study in 2025 (12 payments).
Products named: Viberzi
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Mohammad A. Mahmud, MD, MPH, PHD Internal Medicine · Corona, CA
- Inti Fernandez, M.D General Practice · Miami, FL
- Felix G. Penate, MD Family Medicine · Miami, FL
- John N. Vu, M.D. Family Medicine · Mcdonough, GA
- Joseph M. Buadoo-croffie, MD Pediatric Gastroenterology · Indianapolis, IN
- Shari Rozen, M.D. Family Medicine · Pittsburgh, PA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Riley Hospital for Children at Indiana University Health $10,472
- Valencia Medical & Research $6,465
- Kindred Medical Institute for Clinical Trials LLC $1,290
- Florida Research Center Inc $960
- Preferred Primary Care Physicians $960
- Valencia Medical and Research Center $960
- Clinical Research Institute $960
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.